What are psychedelics?
Psychedelics is an umbrella term for certain types of drugs that are known for their psychoactive effects, and increasingly for their vast therapeutic potential. They include certain types of plants and fungi, and well as synthetic compounds.
What is psychedelic-assisted psychotherapy?
Psychedelic assisted-psychotherapy is a form of psychotherapy that involves the use of psychedelic substances such as psilocybin, MDMA and ketamine for the purpose of facilitating mental wellness, therapeutic breakthroughs, and insight.
It is a broad term that encompasses a number of different approaches and protocols using psychedelics, and which has been practiced in the Western medical model since the 1950s. Though psychedelics like LSD showed promise as therapeutic agents in those early years, a period of prohibition starting in the 1960s and through the early 2000s significantly hindered the research and development of these modalities.
The last decade has seen a significant body of encouraging research supporting the efficacy of psychedelic-assisted psychotherapy for a number of mental health issues, especially depression, anxiety, addiction, and PTSD. Though most psychedelics are still regulated substances, the legal and medical landscape is changing quickly, and more treatment options are starting to become available to the general public.
Is psychedelic-assisted psychotherapy available now?
Yes. Numinus currently offers ketamine-assisted psychotherapy. Additionally, we are undertaking clinical trials with MDMA- and psilocybin-assisted psychotherapy to help further the body of research supporting their approval as treatments for a variety of conditions. We plan to offer these treatments as the regulatory landscape in North America changes, and our Clinical Advisory Board continues to support those policy changes starting here in Canada. Read our recommendation letter to Health Canada for more.